CAVHANZA vs LORBRENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CAVHANZA and LORBRENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	LORBRENA
Rating	New	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB	LORLATINIB
Manufacturer	Flex Pharma	Pfizer
Dosage forms	Tablet, orally disintegrating	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	—

cavhanza lorbrena

Rating

New

64/100

Pharmacy pays

—

Type

Active ingredient

NILOTINIB

LORLATINIB

Manufacturer

Flex Pharma

Pfizer

Dosage forms

Tablet, orally disintegrating

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

—

Frequently asked questions

What is the difference between Cavhanza and Lorbrena?

Cavhanza contains Nilotinib, while Lorbrena contains Lorlatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.